G. Weiner

Oncology · 2010–2015

A researcher in the Science corpus: 2 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom G. Weiner trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Y. Yarden
  2. D. Pardoll
  3. Paul Polakis
  4. S. Maude

Papers from G. Weiner's perspective

Ordered by how strongly the researchers G. Weiner trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
  2. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets (Nature Medicine)
  3. The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
  4. Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria (Clinical Cancer Research)
  5. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients (Nature)
  6. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer… (Journal of the National Cancer Institute)
  7. Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised,… (The Lancet Oncology)
  8. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma (Proceedings of the National Academy of Sciences of the United States of America)
  9. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma (New England Journal of Medicine)
  10. Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes (Science)

Their papers